Simultaneous determination of pioglitazone and candesartan in human plasma by LC-MS/MS and its application to a human pharmacokinetic study

A simple and rapid liquid chromatography-tandem mass spectrometric (LC-MS/MS) assay method has been developed and fully validated for simultaneous quantification of pioglitazone and candesartan in human plasma. Irbesartan was used as an internal standard. The analytes were extracted from human plasm...

Full description

Bibliographic Details
Main Authors: Vijaya Kumari Karra, Nageswara Rao Pilli, Jaswanth Kumar Inamadugu, J.V.L.N. Seshagiri Rao
Format: Article
Language:English
Published: Elsevier 2012-06-01
Series:Journal of Pharmaceutical Analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S2095177912000123
_version_ 1818448099909042176
author Vijaya Kumari Karra
Nageswara Rao Pilli
Jaswanth Kumar Inamadugu
J.V.L.N. Seshagiri Rao
author_facet Vijaya Kumari Karra
Nageswara Rao Pilli
Jaswanth Kumar Inamadugu
J.V.L.N. Seshagiri Rao
author_sort Vijaya Kumari Karra
collection DOAJ
description A simple and rapid liquid chromatography-tandem mass spectrometric (LC-MS/MS) assay method has been developed and fully validated for simultaneous quantification of pioglitazone and candesartan in human plasma. Irbesartan was used as an internal standard. The analytes were extracted from human plasma samples by solid-phase extraction technique using a Strata-X 33 μm polymeric sorbent. The reconstituted samples were chromatographed on a C18 column by using a 80:20 (v/v) mixture of acetonitrile and 0.1% formic acid as the mobile phase at a flow rate of 0.8 mL/min. The calibration curves obtained were linear (râ¥0.99) over the concentration range of 15â3000 ng/mL for pioglitazone and 5â608 ng/mL for candesartan. The results of the intra- and inter-day precision and accuracy studies were well within the acceptable limits. A run time of 2.7 min for each sample made it possible to analyze more than 300 plasma samples per day. The proposed method was found to be applicable to clinical studies. Keywords: Pioglitazone, Candesartan, Human plasma, Solid-phase extraction, LC-MS/MS, Pharmacokinetics
first_indexed 2024-12-14T20:14:08Z
format Article
id doaj.art-3e4f12d3ac094f2ea7a48d9486f608f6
institution Directory Open Access Journal
issn 2095-1779
language English
last_indexed 2024-12-14T20:14:08Z
publishDate 2012-06-01
publisher Elsevier
record_format Article
series Journal of Pharmaceutical Analysis
spelling doaj.art-3e4f12d3ac094f2ea7a48d9486f608f62022-12-21T22:48:53ZengElsevierJournal of Pharmaceutical Analysis2095-17792012-06-0123167173Simultaneous determination of pioglitazone and candesartan in human plasma by LC-MS/MS and its application to a human pharmacokinetic studyVijaya Kumari Karra0Nageswara Rao Pilli1Jaswanth Kumar Inamadugu2J.V.L.N. Seshagiri Rao3University College of Pharmaceutical Sciences, Jawaharlal Nehru Technological University, Kukatpally, Hyderabad-500085, IndiaUniversity College of Pharmaceutical Sciences, Jawaharlal Nehru Technological University, Kukatpally, Hyderabad-500085, IndiaAnalytical and Environmental Chemistry Division, Department of Chemistry, Sri Venkateswara University, Tirupati-517502, IndiaCollege of Pharmaceutical Sciences, Andhra University, Visakhapatnam-530003, India; Corresponding author. +91 9491766577.A simple and rapid liquid chromatography-tandem mass spectrometric (LC-MS/MS) assay method has been developed and fully validated for simultaneous quantification of pioglitazone and candesartan in human plasma. Irbesartan was used as an internal standard. The analytes were extracted from human plasma samples by solid-phase extraction technique using a Strata-X 33 μm polymeric sorbent. The reconstituted samples were chromatographed on a C18 column by using a 80:20 (v/v) mixture of acetonitrile and 0.1% formic acid as the mobile phase at a flow rate of 0.8 mL/min. The calibration curves obtained were linear (râ¥0.99) over the concentration range of 15â3000 ng/mL for pioglitazone and 5â608 ng/mL for candesartan. The results of the intra- and inter-day precision and accuracy studies were well within the acceptable limits. A run time of 2.7 min for each sample made it possible to analyze more than 300 plasma samples per day. The proposed method was found to be applicable to clinical studies. Keywords: Pioglitazone, Candesartan, Human plasma, Solid-phase extraction, LC-MS/MS, Pharmacokineticshttp://www.sciencedirect.com/science/article/pii/S2095177912000123
spellingShingle Vijaya Kumari Karra
Nageswara Rao Pilli
Jaswanth Kumar Inamadugu
J.V.L.N. Seshagiri Rao
Simultaneous determination of pioglitazone and candesartan in human plasma by LC-MS/MS and its application to a human pharmacokinetic study
Journal of Pharmaceutical Analysis
title Simultaneous determination of pioglitazone and candesartan in human plasma by LC-MS/MS and its application to a human pharmacokinetic study
title_full Simultaneous determination of pioglitazone and candesartan in human plasma by LC-MS/MS and its application to a human pharmacokinetic study
title_fullStr Simultaneous determination of pioglitazone and candesartan in human plasma by LC-MS/MS and its application to a human pharmacokinetic study
title_full_unstemmed Simultaneous determination of pioglitazone and candesartan in human plasma by LC-MS/MS and its application to a human pharmacokinetic study
title_short Simultaneous determination of pioglitazone and candesartan in human plasma by LC-MS/MS and its application to a human pharmacokinetic study
title_sort simultaneous determination of pioglitazone and candesartan in human plasma by lc ms ms and its application to a human pharmacokinetic study
url http://www.sciencedirect.com/science/article/pii/S2095177912000123
work_keys_str_mv AT vijayakumarikarra simultaneousdeterminationofpioglitazoneandcandesartaninhumanplasmabylcmsmsanditsapplicationtoahumanpharmacokineticstudy
AT nageswararaopilli simultaneousdeterminationofpioglitazoneandcandesartaninhumanplasmabylcmsmsanditsapplicationtoahumanpharmacokineticstudy
AT jaswanthkumarinamadugu simultaneousdeterminationofpioglitazoneandcandesartaninhumanplasmabylcmsmsanditsapplicationtoahumanpharmacokineticstudy
AT jvlnseshagirirao simultaneousdeterminationofpioglitazoneandcandesartaninhumanplasmabylcmsmsanditsapplicationtoahumanpharmacokineticstudy